These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


129 related items for PubMed ID: 810314

  • 1. Metolazone in essential hypertension: the long-term clinical efficacy of a new diuretic.
    Dornfeld L, Kane RE.
    Curr Ther Res Clin Exp; 1975 Oct; 18(4):527-33. PubMed ID: 810314
    [No Abstract] [Full Text] [Related]

  • 2. [Metolazone, a new diuretic in essential arterial hypertension].
    Basso B, Gac JC, Rebolledo H, Román O, Valenzuela MA, Cespedes E.
    Rev Med Chil; 1986 Feb; 114(2):109-13. PubMed ID: 3532255
    [No Abstract] [Full Text] [Related]

  • 3. Antihypertensive efficacy of metolazone (Zaroxolyn) alone and combined with reserpine in treatment of essential hypertension.
    Van Hoose MC, Cutler RE.
    Curr Ther Res Clin Exp; 1976 Sep; 20(3):266-76. PubMed ID: 822985
    [No Abstract] [Full Text] [Related]

  • 4. Clinical evaluation of metolazone, a long-acting antihypertensive/diuretic.
    Weingarten C.
    Curr Ther Res Clin Exp; 1976 Dec; 20(6):737-44. PubMed ID: 827419
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Long-term treatment of Hypertension with methyldopa. II. Therapeutic efficacy.
    Fitz AE, Saunders E.
    J Cardiovasc Pharmacol; 1981 Dec; 3 Suppl 2():S85-91. PubMed ID: 6172671
    [Abstract] [Full Text] [Related]

  • 9. Clinical studies of a new, low-dose formulation of metolazone for the treatment of hypertension.
    Curry CL, Janda SM, Harris R, MacKay JH, Nugent CA, Ryan J, Schnaper H, Schoenberger J.
    Clin Ther; 1986 Dec; 9(1):47-62. PubMed ID: 3545477
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Metolazone and pindolol in the treatment of hypertension: a double blind multicentre trial.
    Hickey N, O'Donoghue S, Guiry U, Graham I, Mulcahy R, Belton P, Carmody M, Sheridan J, Quigley P, Jackson M.
    Ir Med J; 1982 Jun; 75(6):194-6. PubMed ID: 7050009
    [No Abstract] [Full Text] [Related]

  • 12. Biochemical and clinical effects of metolazone in congestive heart failure.
    Levey BA, Palmer RF.
    Curr Ther Res Clin Exp; 1975 Nov; 18(5):641-51. PubMed ID: 812641
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Long-term treatment of hypertension with methyldopa. VIII. Overview.
    Itskovitz HD.
    J Cardiovasc Pharmacol; 1981 Nov; 3 Suppl 2():S120-7. PubMed ID: 6172668
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Use of metolazone in the treatment of refractory hypertension.
    Benedetto ER.
    Ohio State Med J; 1977 Jan; 73(1):31-3. PubMed ID: 831190
    [No Abstract] [Full Text] [Related]

  • 19. Metolazone for hypertension?
    Drug Ther Bull; 1978 Oct 27; 16(22):87-8. PubMed ID: 710271
    [No Abstract] [Full Text] [Related]

  • 20. Metolazone therapy of patients with mild to moderate hypertension.
    Ward W.
    J S C Med Assoc; 1977 Mar 27; 73(3):99-100. PubMed ID: 266100
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.